Company: ANIX
Filing Date: 2025-09-10
Form Type: 10-Q
Source: 0001493152-25-013000
Chunk: 68

Company: Anixa Biosciences Inc
Filing Date: 2025-09-10
Form: 10-Q
Item: Part I, Item 8
Chunk 68
---
 Data File (formatted in Inline XBRL and contained in Exhibit 101)

22

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.

    ANIXA
    BIOSCIENCES, INC.

    By:
    /s/
    Dr. Amit Kumar

    Dr.
    Amit Kumar

    Chairman
    and Chief Executive Officer 
  
    September
    10, 2025
     
    (Principal
    Executive Officer)

    By:
    /s/
    Michael J. Catelani

    Michael
    J. Catelani

    President,
    Chief Operating Officer and 

    Chief
    Financial Officer

    (Principal
    Financial and
  
    September
    10, 2025
     
    Accounting
    Officer)

23